Back to search
FDAFDA · Food and drugs·Recall number D-1029-2016

Hectorol (doxercalciferol injection) 2 mcg/1mL, Rx only, Manufactured by: Genzyme Biosurgery Corporation 500 Kendall Street, Cambridge, MA 02142, NDC 58468-0126-1

Published June 22, 2016 · Recall initiated: April 27, 2016

Summary

FDA records drug Class III recall D-1029-2016, published June 22, 2016 and initiated April 27, 2016. Recalling firm: Genzyme Corporation / Genzyme Biosurgery; Status: Terminated; Reported quantity: 2350 vials; Lot: Lot #: 6R1001, Exp. 12/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genzyme Corporation / Genzyme Biosurgery
Distributor
MI, PA & NJ
Lot
Lot #: 6R1001, Exp. 12/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hectorol (doxercalciferol injection) 2 mcg/1mL, Rx only, Manufactured by: Genzyme Biosurgery Corporation 500 Kendall Street, Cambridge, MA 02142, NDC 58468-0126-1 recalled?

Yes. FDA published recall D-1029-2016 on June 22, 2016. Reported hazard: Labeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter